It is based upon these lies that the USCCB has concluded that “the reasons to accept the new COVID-19 vaccines from Pfizer and Moderna are sufficiently serious.” The SSPX, in its first stab at the topic, postured as if it is simply a given that exposure to COVID-19 presents “signi...
According to the WHO, 52 vaccine candidates are being developed for COVID-19, some of which are still in the clinical evaluation stage (12). The vaccine developed by pharmaceutical companies Pfizer and BioNTech has been approved for use in some countries in the UK and the USA, which have a...
Furthermore, at the end of July, it was shown that individuals who were infected with COVID-19 in the past were more likely to experience adverse events following immunization with the Pfizer vaccine [40]. These events likely contributed to additional stress in certain communities, triggering ...
They estimated a cost per dose of $0.51–0.76 for a Pfizer/BioNTech-like vaccine and of $1.69–2.53 for a Moderna-like vaccine; however, it is worth noting that they consider a very large production scale (8 billion doses per year), and that fill-finish, packaging, delivery, and R&D ...